Compare SGP & ABX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGP | ABX |
|---|---|---|
| Founded | 2019 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.0M | 930.0M |
| IPO Year | 2026 | 2020 |
| Metric | SGP | ABX |
|---|---|---|
| Price | $29.11 | $8.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $45.00 | $9.50 |
| AVG Volume (30 Days) | 86.8K | ★ 356.0K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | N/A | ★ 205.88 |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $235,237,636.00 |
| Revenue This Year | N/A | $19.18 |
| Revenue Next Year | N/A | $14.60 |
| P/E Ratio | ★ N/A | $64.79 |
| Revenue Growth | N/A | ★ 110.18 |
| 52 Week Low | $17.06 | $7.18 |
| 52 Week High | $30.56 | $12.44 |
| Indicator | SGP | ABX |
|---|---|---|
| Relative Strength Index (RSI) | 55.73 | 34.17 |
| Support Level | $25.00 | $8.35 |
| Resistance Level | $29.90 | $8.89 |
| Average True Range (ATR) | 1.55 | 0.33 |
| MACD | -0.11 | -0.05 |
| Stochastic Oscillator | 55.78 | 5.37 |
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The company operates through four distinct yet complementary divisions: Abacus Life Solutions, Abacus Asset Group, Abacus Intel, and Abacus Wealth Advisors. It operates through three reportable segments, Asset management, Life solutions, and Technology services. It derives the majority revenue from Life solutions segment that generates revenues by buying, selling, and trading policies, and maintaining policies until receipt of death benefits. It also generates revenue by originating life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner.